<p>AstraZeneca said on Tuesday it had submitted a request with US health regulators to grant emergency use authorisation for a new treatment to prevent Covid-19.</p>.<p><strong>Also read: <a href="https://www.deccanherald.com/international/astrazeneca-covid-19-vaccine-shows-74-efficacy-in-large-us-trial-1035706.html" target="_blank">AstraZeneca Covid-19 vaccine shows 74% efficacy in large US trial</a></strong></p>.<p>The British drugmaker had said in August that the treatment, an antibody therapy called AZD7442, had reduced the risk of people developing any Covid-19 symptoms by 77 per cent in a late-stage trial.</p>
<p>AstraZeneca said on Tuesday it had submitted a request with US health regulators to grant emergency use authorisation for a new treatment to prevent Covid-19.</p>.<p><strong>Also read: <a href="https://www.deccanherald.com/international/astrazeneca-covid-19-vaccine-shows-74-efficacy-in-large-us-trial-1035706.html" target="_blank">AstraZeneca Covid-19 vaccine shows 74% efficacy in large US trial</a></strong></p>.<p>The British drugmaker had said in August that the treatment, an antibody therapy called AZD7442, had reduced the risk of people developing any Covid-19 symptoms by 77 per cent in a late-stage trial.</p>